VIEW WEBSITE >
1 known investors
Lario Therapeutics develops first-in-class precision medicines for severe neurological disorders, including epileptic encephalopathies and Parkinson's disease. The company targets disease-modifying treatments based on genetically validated targets.
BiotechDigital Health